Before stopping treatment with Beovu<\/strong><\/p>\n\n\n\nTalk to your doctor before stopping treatment. If you stop treatment, the risk of losing your vision may increase and your vision may deteriorate.
If you have any further questions on the use of this product, ask your doctor.<\/p>\n\n\n\n
4. Possible side effects<\/h2>\n\n\n\n Like all medicines, this medicine can cause side effects , although not everybody gets them. The adverse event was the injection of Beovu come from either the medicine itself or the injection procedure and mostly affect the eye.
Some side effects can be serious<\/strong><\/p>\n\n\n\nBe sure to get immediate care if you get any of the following, which are signs of allergic reactions, inflammation, or infections:<\/p>\n\n\n\n
Sudden deterioration or change in vision.<\/li> Pain, increased discomfort, aggravated redness in the eye.<\/li><\/ul>\n\n\n\nIf you experience any serious side effect is you should notify your doctor immediately.<\/strong>Another possible side effect is<\/strong><\/p>\n\n\n\nOther side effects that may occur after treatment with Beovu are listed below.
Most of the side effects are mild to moderate and generally go away within a week after each injection.
If these side effects get serious, talk to your doctor.
Common<\/strong>: may affect up to 1 in 10 people<\/em><\/p>\n\n\n\ninflammation of the middle membrane of the eye ( uveitis )<\/li> the detachment of the gel-like substance inside the eye (vitreous detachment)<\/li> rupture of the retina (the part in the back of the eye that senses light) or in one of its layers ( rupture of the pigment epithelium)<\/li> impaired vision (impaired visual acuity )<\/li> retinal hemorrhage (retinal hemorrhage)<\/li> inflammation of the iris, the colored part of the eye ( iritis )<\/li> cloud of the lens of the eye ( cataract )<\/li> bleeding from small blood vessels in the outer layer of the eye ( conjunctival bleeding)<\/li> dots moving in the field of view et (clouds in vitreous en)<\/li> eye pain<\/li> higher pressure inside the eye (increased intraocular pressure )<\/li> redness of the whites of the eyes ( conjunctivitis )<\/li> blurred vision or poor visual acuity<\/li> abrasions on the cornea, damage to the clear layer of the eyeball covering the iris(corneal abrasion)<\/li> damage to the clear layer of the eyeball covering the iris (punctate keratitis )<\/li> allergic reactions (hypersensitivity)<\/li><\/ul>\n\n\n\nUncommon<\/strong>: may affect up to 1 in 100 people<\/em><\/p>\n\n\n\nsevere inflammation inside the eye ( endophthalmitis )<\/li> blindness<\/li> sudden loss of vision due to blockage of an artery in the eye ( occlusion of the retinal artery)<\/li> the detachment of the retina (retinal)<\/li> redness of the eye ( conjunctival hyperemia )<\/li> increased tear production<\/li> abnormal sensation in the eye<\/li> the detachment of one of the layers in the retina (pigment epithelial detachment)<\/li> inflammation of the gel-like substance inside the eye (vitrite)<\/li> inflammation of the anterior part of the eye ( inflammation or “flare” in the anterior chamber)<\/li> inflammation of the iris and its adjacent tissue of the eye ( iridocyclitis )<\/li> swelling of the cornea, clear layers of the eyeball (corneal edema)<\/li> bleeding in the eye (bleeding in vitreous en)<\/li><\/ul>\n\n\n\nNo known frequency<\/strong> (cannot be calculated from the available data):<\/p>\n\n\n\nsudden loss of vision due to blockage of blood vessels in the back of the eye (retinal vascular occlusion )<\/li> inflammation of blood vessels in the back of the eye (retinal vasculitis)<\/li><\/ul>\n\n\n\nReporting of side effects<\/em><\/p>\n\n\n\nIf you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly to the Medical Products Agency, www.lakemedelsverket.se. By reporting side effects, you can help increase drug safety information. <\/p>\n\n\n\n
5. How to store Beovu<\/h2>\n\n\n\n Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and label after EXP. The expiration date is the last day of the specified month.
Store in a refrigerator (2 \u00b0 C \u2011 8 \u00b0 C).
Do not freeze.
Keep the vial in the outer carton. Sensitive to light.
Before use, the unopened vial can be stored at room temperature (below 25 \u00b0 C) for up to 24 hours.<\/p>\n\n\n\n
6. Contents of the packaging and other information<\/h2>\n\n\n\nContent declaration<\/h2>\n\n\n\nThe active substance is brolucizumab. One ml solution for injection contains 120 mg of brolucizumab. Each vial contains 27.6 mg brolucizumab in 0.23 ml solution. This corresponds to a usable amount sufficient to administer a single dose of 0.05 ml solution, containing 6 mg brolucizumab.<\/li> The other ingredients are sodium citrate, sucrose, polysorbate 80, and water for injections.<\/li><\/ul>\n\n\n\nWhat the medicine looks like and the contents of the pack<\/h2>\n\n\n\n Beovu 120 mg\/ml solution for injection ( injection ) is a clear to slightly opalescent, colorless to the slightly brownish-yellow aqueous solution.
Each pack contains 1 vial and 1 blunt filter needle (18G x 1\u00bd inch, 1.2 mm x 40 mm, 5 \u03bcm) for single use only.<\/p>\n\n\n\n
Marketing Authorization Holder and Manufacturer<\/h2>\n\n\n\n Marketing Authorisation Holder<\/strong><\/p>\n\n\n\nNovartis Europharm Limited<\/p>\n\n\n\n
Vista Building<\/p>\n\n\n\n
Elm Park, Merrion Road<\/p>\n\n\n\n
Dublin 4,<\/p>\n\n\n\n
Ireland
Manufacturer<\/strong><\/p>\n\n\n\nSA ALCON-COUVREUR NV<\/p>\n\n\n\n
Rijksweg 14<\/p>\n\n\n\n
2870 Puurs<\/p>\n\n\n\n
Belgium
Contact the representative of the marketing authorization holder to find out more about this medicine:<\/p>\n\n\n\nBelgium \/ Belgique \/ Belgien<\/strong>Novartis Pharma NVTel: +32 2 246 16 11<\/td>Lithuania<\/strong>SIA Novartis Baltics Lithuanian branchesTel: +370 5 269 16 50<\/td><\/tr>Bulgaria<\/strong>Novartis Bulgaria EOODTel .: +359 2 489 98 28<\/td>Luxembourg \/ Luxemburg<\/strong>Novartis Pharma NVTel: +32 2 246 16 11<\/td><\/tr>Czech Republic<\/strong>Novartis sroTel: +420 225 775 111<\/td>Hungary<\/strong>Novartis Hungary Kft.Tel .: +36 1 457 65 00<\/td><\/tr>Denmark<\/strong>Novartis Healthcare A \/ STel: +45 39 16 84 00<\/td>Malta<\/strong>Novartis Pharma Services Inc.Tel: +356 2122 2872<\/td><\/tr>Germany<\/strong>Novartis Pharma GmbHTel: +49 911 273 0<\/td>The Netherlands<\/strong>Novartis Pharma BVTel: +31 88 04 52 111<\/td><\/tr>Eesti<\/strong>SIA Novartis Baltics Eesti subsidiaryTel: +372 66 30 810<\/td>Norway<\/strong>Novartis Norge ASTel: +47 23 05 20 00<\/td><\/tr>Greece<\/strong>Novartis (Hellas) AEBE:\u0397\u03bb: +30 210 281 17 12<\/td>Austria<\/strong>Novartis Pharma GmbHTel: +43 1 86 6570<\/td><\/tr>Spain<\/strong>Novartis Pharmac\u00e9utica, SATel: +34 93 306 42 00<\/td>Poland<\/strong>Novartis Poland Sp. z ooTel .: +48 22 3754888<\/td><\/tr>France<\/strong>Novartis Pharma SASTel: +33 1 55 47 66 00<\/td>Portugal<\/strong>Novartis Farma Pharmaceutical Products, SATel: +351 21 000 8600<\/td><\/tr>Croatia<\/strong>Novartis Hrvatska dooTel. +385 1 6274 220<\/td>Romania<\/strong>Novartis Pharma Services Romania SRLTel: +40 21 31299 01<\/td><\/tr>Ireland<\/strong>Novartis Ireland LimitedTel: +353 1 260 12 55<\/td>Slovenia<\/strong>Novartis Pharma Services Inc.Tel: +386 1 300 75 50<\/td><\/tr>Iceland<\/strong>Vistor hf.Phone: +354 535 7000<\/td>Slovak Republic<\/strong>Novartis Slovakia sroTel: +421 2 5542 5439<\/td><\/tr>Italy<\/strong>Novartis Farma SpATel: +39 02 96 54 1<\/td>Finland \/ Finland<\/strong>Novartis Finland OyPuh \/ Tel: +358 (0) 10 6133 200<\/td><\/tr>\u039a\u03cd\u03c0\u03c1\u03bf\u03c2<\/strong>Novartis Pharma Services Inc.:\u0397\u03bb: +357 22 690 690<\/td><\/td><\/tr> Latvia<\/strong>SIA Novartis BalticsTel: +371 67 887 070<\/td>United Kingdom<\/strong>Novartis Pharmaceuticals UK Ltd.Tel: +44 1276 698370<\/td><\/tr><\/tbody><\/table><\/figure>\n","protected":false},"excerpt":{"rendered":"Beovu contains the active substance brolucizumab, which belongs to a group of medicines called antineovascular agents. Beovu is injected into your eye by your doctor for the treatment of a disease called neovascular (wet) age-related macular degeneration (AMD).<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"cybocfi_hide_featured_image":"","footnotes":""},"categories":[2202,2200],"tags":[9083,9085,9078,9082,9080,9087,9086,9081,9084,9079],"class_list":["post-5972","post","type-post","status-publish","format-standard","hentry","category-b","category-medicines","tag-beovu","tag-beovu-injection","tag-brolucizumab","tag-brolucizumab-injection","tag-brolucizumab-side-effects","tag-side-effects-of-beovu","tag-what-beovu-is-used-for","tag-what-brolucizumab-is-used-for","tag-what-is-beovu","tag-what-is-brolucizumab"],"_links":{"self":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts\/5972","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/comments?post=5972"}],"version-history":[{"count":5,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts\/5972\/revisions"}],"predecessor-version":[{"id":12089,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts\/5972\/revisions\/12089"}],"wp:attachment":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/media?parent=5972"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/categories?post=5972"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/tags?post=5972"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}